Sign inJoin waitlistJoin the waitlist

Renato Martins

Division Chief · Virginia Commonwealth University Health System

Credentials: · · · · ·

History

Virginia Commonwealth University Health System
Present

Medical Oncology
1995–1997
Internal Medicine
1992–1995
Doctor of Medicine
1988–1992

Research

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
New England Journal of Medicine · 2012 · 6,533 citations
Erlotinib in previously treated non-small-cell lung cancer
New England Journal of Medicine · 2005 · 4,511 citations
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
The Lancet Oncology · 2016 · 1,187 citations

Keith Eaton
34 papers
Douglas Wood
20 papers
Cristina Rodriguez
18 papers
DE
David Ettinger
18 papers
Christine Baik
17 papers
Thomas D'Amico
17 papers
GO
Gregory Otterson
16 papers
GR
Gregory Riely
16 papers · 1 as a fellow
Lucian Chirieac
16 papers
Wallace Akerley
16 papers
RD
Rafael Santana Davila
15 papers
Ramaswamy Govindan
15 papers

Grants

Massey Cancer Center - Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $465.6K · Virginia Commonwealth University
1995–2028
Fred Hutchinson Cancer Center Lung SPORE
National Cancer Institute · P50
Project lead · $335.2K · Fred Hutchinson Cancer Center
2019–2025

Clinical trials

Study of Nicotine for Pain Associated With Chemotherapy-Induced Peripheral Neuropathy
Principal investigator · Terminated · Phase 2
Virginia Commonwealth University
2020–2022
Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer
Principal investigator · Completed · Phase 2
University of Washington
2012–2017
Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer
Principal investigator · Completed · Phase 2
University of Washington
2007–2015
Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Principal investigator · Completed · Phase 2
University of Washington
2006